{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:57:36Z","timestamp":1760144256958,"version":"build-2065373602"},"reference-count":13,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue de Pneumologie Clinique"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.pneumo.2017.03.004","type":"journal-article","created":{"date-parts":[[2017,4,12]],"date-time":"2017-04-12T23:15:25Z","timestamp":1492038925000},"page":"135-139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Efficacit\u00e9 de l\u2019erlotinib en r\u00e9animation chez les patients pr\u00e9sentant un cancer bronchique non \u00e0 petites cellules avec une mutation de l\u2019EGFR"],"prefix":"10.1016","volume":"73","author":[{"given":"M.","family":"Dewolf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Dayen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Garoute","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Khamis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Fourrier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Rousselle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Sadki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Le Meunier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Suguenot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Lecuyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Bentayeb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Douadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Berna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pneumo.2017.03.004_bib0070","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.lungcan.2013.03.001","article-title":"Major changes in lung cancer over the last ten years in France: the KBP-CPHG studies","volume":"81","author":"Locher","year":"2013","journal-title":"Lung Cancer"},{"key":"10.1016\/j.pneumo.2017.03.004_bib0075","first-page":"727","article-title":"Epidemiologic of primary bronchial carcinoma management in the general French hospital centers","volume":"19","author":"Blanchon","year":"2002","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.pneumo.2017.03.004_bib0080","doi-asserted-by":"crossref","first-page":"E822","DOI":"10.1002\/ijc.27396","article-title":"Epidermal growth factor receptor-tyrosine kinase inhibitor therapy is effective as first-line treatment of advanced non-small-cell lung cancer with mutated EGFR: a meta-analysis from six phase III randomized controlled trials","volume":"131","author":"Gao","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.pneumo.2017.03.004_bib0085","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1093\/jnci\/djt072","article-title":"Impact of EGFR inhibitor in non-small cell lung cancer on progression-free and overall survival: a meta-analysis","volume":"105","author":"Lee","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.pneumo.2017.03.004_bib0090","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1378\/chest.14-2299","article-title":"Critical care use in patients with lung cancer","volume":"147","author":"Soares","year":"2015","journal-title":"Chest"},{"key":"10.1016\/j.pneumo.2017.03.004_bib0095","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1056\/NEJMoa0904554","article-title":"Screening for epidermal growth factor receptor mutations in lung cancer","volume":"361","author":"Rosell","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pneumo.2017.03.004_bib0100","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S1470-2045(11)70184-X","article-title":"Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (Optimal, CTONG-0802): a multicentre, open-label, randomised, phase 3\u00a0study","volume":"12","author":"Zhou","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.pneumo.2017.03.004_bib0105","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1200\/JCO.2011.40.0846","article-title":"Intensive care unit outcomes among patients with lung cancer in the surveillance, epidemiology, and end results\u2013medicare registry","volume":"30","author":"Slatore","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.pneumo.2017.03.004_bib0110","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s00134-014-3535-x","article-title":"Patients with advanced lung cancer harboring oncogenic mutations should be admitted to intensive care units","volume":"41","author":"Toffart","year":"2015","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.pneumo.2017.03.004_bib0115","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1471-2253-14-55","article-title":"The impact of rescue or maintenance therapy with EGFR TKIs for Stage IIIb-IV non-squamous non-small-cell lung cancer patients requiring mechanical ventilation","volume":"14","author":"Hsia","year":"2014","journal-title":"BMC Anesthesiol"},{"key":"10.1016\/j.pneumo.2017.03.004_bib0120","unstructured":"http:\/\/www.ema.europa.eu\/docs\/fr_FR\/document_library\/EPAR_-_Product_Information\/human\/000618\/WC500033994.pdf."},{"key":"10.1016\/j.pneumo.2017.03.004_bib0125","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.lungcan.2014.07.010","article-title":"Successful empirical erlotinib treatment of a mechanically ventilated patient newly diagnosed with metastatic lung adenocarcinoma","volume":"86","author":"Bosch-Barrera","year":"2014","journal-title":"Lung Cancer"},{"key":"10.1016\/j.pneumo.2017.03.004_bib0065","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12890-016-0205-5","article-title":"Early mortality in lung cancer: French prospective multicentre observational study","volume":"16","author":"Grivaux","year":"2016","journal-title":"BMC Pulm Med"}],"container-title":["Revue de Pneumologie Clinique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0761841716300578?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0761841716300578?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:17:28Z","timestamp":1760105848000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0761841716300578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S0761841716300578"],"URL":"https:\/\/doi.org\/10.1016\/j.pneumo.2017.03.004","relation":{},"ISSN":["0761-8417"],"issn-type":[{"type":"print","value":"0761-8417"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacit\u00e9 de l\u2019erlotinib en r\u00e9animation chez les patients pr\u00e9sentant un cancer bronchique non \u00e0 petites cellules avec une mutation de l\u2019EGFR","name":"articletitle","label":"Article Title"},{"value":"Revue de Pneumologie Clinique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pneumo.2017.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}